Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When will livalo go generic?Dulera coupons discounts?Caverject alternatives?Bromocriptine manufacturers?Tri lo sprintec price?
See the DrugPatentWatch profile for aranesp
Aranesp (darbepoetin alfa) is used to treat certain types of anemia where the body is not making enough red blood cells, or where kidney disease or cancer treatment can cause anemia. It works by boosting erythropoietin activity, which helps the bone marrow produce more red blood cells.
Common uses include: - Anemia related to chronic kidney disease (including patients on dialysis and not on dialysis). - Anemia in people with cancer who are receiving chemotherapy and may be at risk for low red blood cell counts (to reduce the need for red blood cell transfusions).
No. Aranesp is typically used for anemia in specific settings (like chronic kidney disease or chemotherapy-associated anemia). It is not a general treatment for any low hemoglobin situation.
When Aranesp is effective, hemoglobin levels rise and anemia-related symptoms (such as fatigue) may improve. Treatment decisions are usually based on hemoglobin trends and clinical guidelines rather than symptoms alone.
Other Questions About Aranesp :